Mayne Pharma Group's total assets for Q4 2025 were AU$1.01B, a decrease of -10.27% from the previous quarter. MAYNF total liabilities were AU$644.32M for the fiscal quarter, a -5.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.